Monocyte-to-HDL-Cholesterol Ratio as an Independent Predictor of Cardiovascular Risk in Patients with Hyperuricemia
Background: Hyperuricemia contributes to cardiovascular disease (CVD) through oxidative stress, endothelial dysfunction, and chronic inflammation. The monocyte-to-HDL-cholesterol ratio (MHR) is a novel inflammatory biomarker reflecting the balance between pro-inflammatory monocytes and the anti-inflammatory effects of...